Patent ID: 8535641
Filing Date: 2013-09-17
Classification: A61K,A61P,C07F,C12Q,G01N

Abstract:
1. A method for the treatment of a cancer in a subject comprising administering to the subject an effective amount of a molecule comprising a phospholipid ether analog, wherein the phospholipid ether analog is 18-(p-iodophenyl)octadecyl phosphocholine wherein the iodo moiety of the 18-(p-iodophenyl)octadecyl phosphocholine is 125 I or 131 I, and wherein said cancer is selected from the group consisting of lung cancer, squamous cell carcinoma, melanoma, colorectal cancer, ovarian cancer, prostate cancer, glioma, breast cancer, carcinosarcoma, and pancreatic cancer.